Page last updated: 2024-08-21

oleanolic acid and Pulmonary Hypertension

oleanolic acid has been researched along with Pulmonary Hypertension in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (25.00)	29.6817
2010's	2 (50.00)	24.3611
2020's	1 (25.00)	2.80

Authors

Authors	Studies
Medrek, S; Melendres-Groves, L	1
Chen, X; Cheng, Y; Gong, Y; Huang, Z; Kong, H; Li, H; Mou, Y; Qian, S; Wang, H; Xie, W; Zhang, Y	1
He, ZX; Wang, YY; Yang, YX; Zhe, H; Zhou, SF	1
Bedja, D; Biswal, S; Blake, DJ; Champion, HC; El-Haddad, H; Gabrielson, KL; Kensler, TW; Kombairaju, P; Liby, KT; Malhotra, D; Rangasamy, T; Sporn, MB; Sussan, TE; Tuder, RM; Yamamoto, M; Yates, MS	1

Reviews

2 review(s) available for oleanolic acid and Pulmonary Hypertension

Article	Year
Evolving nonvasodilator treatment options for pulmonary arterial hypertension. Current opinion in pulmonary medicine, 2022, 09-01, Volume: 28, Issue:5 Topics: Familial Primary Pulmonary Hypertension; Humans; Hypertension, Pulmonary; Oleanolic Acid; Pulmonary Arterial Hypertension; Pulmonary Artery	2022
Bardoxolone methyl (CDDO-Me) as a therapeutic agent: an update on its pharmacokinetic and pharmacodynamic properties. Drug design, development and therapy, 2014, Volume: 8 Topics: Animals; Humans; Hypertension, Pulmonary; Inflammation; Neoplasms; Oleanolic Acid; Renal Insufficiency, Chronic	2014

Other Studies

2 other study(ies) available for oleanolic acid and Pulmonary Hypertension

Article	Year
Identification of a Novel Hybridization from Isosorbide 5-Mononitrate and Bardoxolone Methyl with Dual Activities of Pulmonary Vasodilation and Vascular Remodeling Inhibition on Pulmonary Arterial Hypertension Rats. Journal of medicinal chemistry, 2018, 02-22, Volume: 61, Issue:4 Topics: Animals; Cardiomegaly; Drug Design; Fibrosis; Hypertension, Pulmonary; Isosorbide Dinitrate; Nitric Oxide Donors; Oleanolic Acid; Rats; Vascular Remodeling; Vasodilation	2018
Targeting Nrf2 with the triterpenoid CDDO-imidazolide attenuates cigarette smoke-induced emphysema and cardiac dysfunction in mice. Proceedings of the National Academy of Sciences of the United States of America, 2009, Jan-06, Volume: 106, Issue:1 Topics: Animals; Apoptosis; Drug Delivery Systems; Heart Diseases; Hypertension, Pulmonary; Imidazoles; Mice; Mice, Knockout; NF-E2-Related Factor 2; Nitric Oxide; Oleanolic Acid; Oxidative Stress; Pulmonary Alveoli; Pulmonary Disease, Chronic Obstructive; Pulmonary Emphysema; Smoke	2009

Article

Year

Identification of a Novel Hybridization from Isosorbide 5-Mononitrate and Bardoxolone Methyl with Dual Activities of Pulmonary Vasodilation and Vascular Remodeling Inhibition on Pulmonary Arterial Hypertension Rats.

Journal of medicinal chemistry, 2018, 02-22, Volume: 61, Issue:4

Topics: Animals; Cardiomegaly; Drug Design; Fibrosis; Hypertension, Pulmonary; Isosorbide Dinitrate; Nitric Oxide Donors; Oleanolic Acid; Rats; Vascular Remodeling; Vasodilation

2018

Targeting Nrf2 with the triterpenoid CDDO-imidazolide attenuates cigarette smoke-induced emphysema and cardiac dysfunction in mice.

Proceedings of the National Academy of Sciences of the United States of America, 2009, Jan-06, Volume: 106, Issue:1

Topics: Animals; Apoptosis; Drug Delivery Systems; Heart Diseases; Hypertension, Pulmonary; Imidazoles; Mice; Mice, Knockout; NF-E2-Related Factor 2; Nitric Oxide; Oleanolic Acid; Oxidative Stress; Pulmonary Alveoli; Pulmonary Disease, Chronic Obstructive; Pulmonary Emphysema; Smoke

2009